共 48 条
[1]
Xia Y(2023)The efficacy and hemorheological indexes of ginseng and its active components for patients with non-small cell lung cancer: a systematic review and meta-analysis J Oncol 2023 3144086-367
[2]
Han H(2008)Small cell lung cancer Mayo Clin Proc 83 355-751
[3]
Gu R(2020)Emerging therapeutic agents for advanced non-small cell lung cancer J Hematol Oncol 13 58-49
[4]
Tao R(1985)Smoking and other risk factors for lung cancer in women J Natl Cancer Inst 74 747-500
[5]
Lu K(2003)Epidemiology of lung cancer Chest 123 21-206
[6]
Sun Z(2022)Analysis of the efficacy and safety of amivantamab in non-small cell lung cancer patients with EGFR/MET gene abnormalities: a single center's experience Chin J Cancer 25 493-16
[7]
Shen S(2023)Targeting EGFR Exon 20 insertion mutation in non-small cell lung cancer: amivantamab and mobocertinib Ann Pharmacother 57 198-undefined
[8]
Wang A(2022)Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer Expert Rev Anticancer Ther 22 3-undefined
[9]
Lu Y(2022)Development and validation of a LC-MS/MS method for simultaneous quantification of Ivabradine and metoprolol in rat plasma J Pharmacol Toxicol Methods 116 107186-undefined
[10]
Sher T(2019)AAPS Workshop Report on ICH M10 AAPS 22 10-undefined